The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials
JBI Evidence Synthesis · 2023-03 · 21 (3) · 494-506
DOI: 10.11124/jbies-22-00430 ↗Kurz gefasst
Fachartikel in der Zeitschrift JBI Evidence Synthesis, 2023-03. Verfasst von Timothy Hugh Barker und 7 weiteren Autor:innen. Beteiligte Einrichtung: JBI, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 1100-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
JBI recently began the process of updating and revising its suite of critical appraisal tools to ensure that these tools remain compatible with recent developments within risk of bias science. Following a rigorous development process led by the JBI Effectiveness Methodology Group, this paper presents the revised critical appraisal tool for the assessment of risk of bias for randomized controlled trials. This paper also presents practical guidance on how the questions of this tool are to be interpreted and applied by systematic reviewers, while providing topical examples. We also discuss the major changes made to this tool compared to the previous version and justification for why these changes facilitate best-practice methodologies in this field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- JBI, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
- Queen's Collaboration for Health Care Quality, Queen's University, Kingston, ON, Canada.
- Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, The Czech Republic (Middle European) Centre for Evidence-Based Healthcare: A JBI Centre of Excellence, Masaryk Univ…
- Centre for Health Informatics, Australian Institute of Health Innovation, Macquarie University, Sydney, NSW, Australia.
- The Nottingham Centre for Evidence Based Healthcare: A JBI Centre of Excellence, School of Medicine, University of Nottingham, Nottingham, UK.
Zitieren
APA
Barker, T. H., Stone, J. C., Sears, K., Klugar, M., Tufanaru, C., Leonardi-Bee, J., Aromataris, E., & Munn, Z. (2023). The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI Evidence Synthesis, 21(3), 494-506. https://doi.org/10.11124/jbies-22-00430
Vancouver
Barker TH, Stone JC, Sears K, Klugar M, Tufanaru C, Leonardi-Bee J, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI Evidence Synthesis. 2023;21(3):494-506. doi:10.11124/jbies-22-00430
BibTeX
@article{Barker2023,
author = {Barker, Timothy Hugh and Stone, Jennifer C and Sears, Kim and Klugar, Miloslav and Tufanaru, Catalin and Leonardi-Bee, Jo and Aromataris, Edoardo and Munn, Zachary},
title = {The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials},
journal = {JBI Evidence Synthesis},
year = {2023},
volume = {21},
number = {3},
pages = {494--506},
doi = {10.11124/jbies-22-00430}
}
EUVIMED